- Statement of FTC Bureau of Competition Deputy Director Rahul Rao on Lawsuit Against PBMs and the Role of Drug Manufacturers in Distorting Competition in the U.S Drug Distribution System ( )
- FDA Draft Guidance Biosimilar Drugs Comment Letter ( )
- Statement of Commissioner Rebecca Kelly Slaughter Regarding FTC Staff Interim Report: Pharmacy Benefit Managers ( )
- Statement of Chair Lina M. Khan Joined by Commissioners Alvaro M. Bedoya & Rebecca Kelly Slaughter Regarding the Pharmacy Benefit Managers Interim Staff Report ( )
- Dissenting Statement of Commissioner Melissa Holyoak In the Matter of the Pharmacy Benefit Managers Report ( )
- Concurring Statement of Commissioner Andrew N. Ferguson Regarding the Pharmacy Benefit Managers Interim Staff Report ( )
- Statement of Commissioner Rebecca Kelly Slaughter Regarding the Eyeglass Rule ( )
- Chair Khan Opening Statement at House Committee on Appropriations , Subcommittee on Financial Services and General Government ( )
- Remarks by Chair Lina M. Khan As Prepared for Delivery at White House Event on Lowering Healthcare Costs ( )
- Remarks by Chair Lina M. Khan As Prepared for Delivery at the Private Capital, Public Impact Workshop on Private Equity in Healthcare ( )
- Remarks by Chair Lina M. Khan As Prepared for Delivery for White House Roundtable on PBMs ( )
- Remarks by Chair Lina M. Khan at American Medical Association National Advocacy Conference ( )
- Comment of the United States Federal Trade Commission - Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights ( )
- Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter In the Matter of Sanofi/Maze Therapeutics ( )
- Statement of Chair Lina M. Khan at the September Open Commission Meeting on Brand Drug Manufacturers’ Improper Listing of Patents in the Orange Book ( )
- Statement of Chair Lina M. Khan Regarding the Policy Statement Concerning Reliance on Prior PBM-Related Advocacy Statements and Reports ( )
- Statement of Commissioner Rebecca Kelly Slaughter Regarding the Health Breach Notification Rule and the Biometric Policy Statement as Prepared for Delivery ( )
- Statement of Commissioner Rebecca Kelly Slaughter regarding the Health Breach Notification Rule and the Biometric Policy Statement ( )
- Remarks of Chair Khan at the May 2023 Open Commission Meeting ( )
- Statement of Commissioner Alvaro M. Bedoya Joined by Commissioner Rebecca Kelly Slaughter Regarding Amazon.com, Inc.'s Acquisition of 1Life Healthcare, Inc. ( )
- Remarks of Chair Lina M. Khan at the American Economic Liberties Project and the National Community Pharmacists Association Event Titled How Pharmacy Benefit Managers Impact Drug Prices, Communities, and Patients ( )
- Policy Statement of the Federal Trade Commission on Rebates and Fees in Exchange for Excluding Lower Cost Drug Products ( )
- Oral Remarks of Christine S. Wilson at Open Commission Meeting on June 16, 2022 ( )
- Statement of Commissioner Rebecca Kelly Slaughter Regarding the Policy Statement of the Federal Trade Commission on Rebates and Fees in Exchange for Excluding Lower-Cost Drug Products ( )
- Statement of Commissioner Christine S. Wilson Regarding the FTC Policy Statement on Rebates and Fees in Exchange for Excluding Lower Cost Drug Products ( )
- Statement of Commissioner Alvaro M. Bedoya Regarding the Commission's Policy Statement on Rebates and Fees in Exchange for Excluding Lower-Cost Drug Products ( )
- Remarks of Chair Lina M. Khan Regarding Policy Statement on Rebates and Fees in Exchange for Excluding Lower-Cost Drug Products ( )
- Concurring Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding 6(b) Study of Pharmacy Benefit Managers ( )
- Statement of Chair Lina M. Khan Regarding 6(b) Study of Pharmacy Benefit Managers ( )
- Statement of Commissioner Rebecca Kelly Slaughter Regarding 6(b) Study of Pharmacy Benefit Managers ( )
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.